Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

187.77
Delayed Data
As of Oct 23
 -0.51 / -0.27%
Today’s Change
182.80
Today|||52-Week Range
256.80
-10.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash7.6B1.7B1.1B886.9M
 
 
 
 
 
Short Term Investment Cash7.1B-5.8B-631.1M-206.0M
 
 
 
 
 
Cash & Short Term Investments27.4B13.2B9.0B5.8B
 
 
 
 
 
 
ReceivablesReceivables2.4B2.6B2.5B2.8B
 
 
 
 
 
 
InventoriesInventories705.5M718.0M904.7M935.9M
 
 
 
 
 
 
Current AssetsPrepaid Expenses--983.1M----
 
 
Other Current Assets1.2B306.0M1.3B875.5M
 
 
 
 
 
Current Assets31.7B17.9B13.7B10.4B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--2.0B----
 
 
Depreciation---407.4M----
 
 
Intangible Assets109.6B109.0B110.9B112.0B
 
 
 
 
 
Other Assets110.1B109.2B111.1B112.1B
 
 
 
 
 
Total Assets143.6B129.0B126.8B124.7B
 
 
 
 
 
 
LiabilitiesAccounts Payable296.5M224.9M292.2M304.0M
 
 
 
 
 
Short Term Debt1.6B2.8B5.5B3.8B
 
 
 
 
 
Accrued Expenses3.5B3.0B2.9B3.1B
 
 
 
 
 
Other Current Liabilities4.9B4.2B4.0B3.8B
 
 
 
 
 
Other Liabilities8.0B7.9B10.4B8.6B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt31.2B30.0B26.2B26.4B
 
 
 
 
 
Deferred Taxes-12.7B-12.7B-12.8B-12.2B
 
 
 
 
 
Other Liabilities184.5M156.5M161.0M158.7M
 
 
 
 
 
Total Liabilities53.9B52.8B51.6B49.5B
 
 
 
 
 
 
EquityMinority Interest-1.8M-1.8M-1.0M-2.0M
 
 
 
 
 
Preferred Stock4.9B4.9B4.9B4.9B
 
 
 
 
 
Common Equity84.8B71.3B70.3B70.3B
 
 
 
 
 
Total Shareholder Equity89.7B76.2B75.2B75.2B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding383.2M334.9M335.6M334.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.